We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+13.13%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$1.11B
AUM Growth
+$28.9M
Cap. Flow
-$70.4M
Cap. Flow %
-6.34%
Top 10 Hldgs %
20.71%
Holding
564
New
93
Increased
113
Reduced
193
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Financials 9.74%
3 Healthcare 8.27%
4 Industrials 8.16%
5 Consumer Discretionary 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
101
Costco
COST
$424B
$3.04M 0.27%
8,064
+194
+2% +$72.5K
AGG icon
102
iShares Core US Aggregate Bond ETF
AGG
$139B
$3.01M 0.27%
25,453
-990
-4% -$117K
XEL icon
103
Xcel Energy
XEL
$48.5B
$3M 0.27%
44,922
-40,369
-47% -$2.81M
LLY icon
104
Eli Lilly
LLY
$1.06T
$2.93M 0.26%
17,340
-27,607
-61% -$4.12M
EOG icon
105
EOG Resources
EOG
$76B
$2.91M 0.26%
58,399
-26,821
-31% -$1.17M
NVMI
106
Nova
NVMI
$11.7B
$2.89M 0.26%
40,985
-20,880
-34% -$1.3M
SIVB
107
DELISTED
SVB Financial Group
SIVB
$2.89M 0.26%
+7,457
New +$2.42M
GVI icon
108
iShares Intermediate Government/Credit Bond ETF
GVI
$3.82B
$2.77M 0.25%
23,566
+260
+1% +$30.5K
MRK icon
109
Merck
MRK
$378B
$2.75M 0.25%
35,170
-3,089
-8% -$236K
PIPR icon
110
Piper Sandler
PIPR
$5.26B
$2.52M 0.23%
99,800
-11,600
-10% -$263K
NEM icon
111
Newmont
NEM
$139B
$2.52M 0.23%
41,996
-13,251
-24% -$817K
TSM icon
112
TSMC
TSM
$2.17T
$2.49M 0.22%
22,803
+22,365
+5,106% +$2.12M
GS icon
113
Goldman Sachs
GS
$303B
$2.37M 0.21%
8,990
-1,677
-16% -$373K
CCMP
114
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$2.33M 0.21%
15,382
-28,569
-65% -$4.28M
LGIH icon
115
LGI Homes
LGIH
$1.35B
$2.33M 0.21%
21,973
+18,830
+599% +$2.14M
DHR icon
116
Danaher
DHR
$152B
$2.27M 0.2%
+11,538
New +$2.31M
ALL icon
117
Allstate
ALL
$66.2B
$2.27M 0.2%
20,637
-3,874
-16% -$381K
PATK icon
118
Patrick Industries
PATK
$2.69B
$2.2M 0.2%
48,197
-3,900
-7% -$165K
AES icon
119
AES
AES
$10.5B
$2.18M 0.2%
92,861
-59,988
-39% -$1.25M
NOC icon
120
Northrop Grumman
NOC
$78.1B
$2.11M 0.19%
6,924
-10,221
-60% -$3.13M
CNXN icon
121
PC Connection
CNXN
$2B
$2.06M 0.19%
43,617
-676
-2% -$31.1K
REGI
122
DELISTED
Renewable Energy Group, Inc.
REGI
$2.05M 0.18%
+28,891
New +$1.77M
TLH icon
123
iShares 10-20 Year Treasury Bond ETF
TLH
$11.1B
$2M 0.18%
12,583
-11,631
-48% -$1.88M
KRE icon
124
State Street SPDR S&P Regional Banking ETF
KRE
$4.05B
$2M 0.18%
+38,453
New +$1.76M
SEE
125
DELISTED
Sealed Air
SEE
$1.96M 0.18%
+42,870
New +$1.86M

Similar funds

James Investment Research's Q4 2020 Portfolio in Review

As of Q4 2020, James Investment Research held 564 positions worth $1.11B, up 2.7% from $1.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

James Investment Research withdrew a net $70.4M in Q4 2020, closing 56 positions and reducing 193 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $4.67M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, James Investment Research opened a new position in Vanguard Morningstar Small-Cap Value ETF worth $15.4M.

  • James Investment Research's largest Q4 2020 buy was Vanguard Morningstar Small-Cap Value ETF: 108,050 shares worth $15.4M.
  • James Investment Research added most to iShares Russell 2000 Value ETF in Q4 2020, an estimated $15.2M increase.
  • James Investment Research's biggest Q4 2020 reduction was Microsoft, cutting an estimated $11.7M.
  • James Investment Research fully exited Regeneron Pharmaceuticals in Q4 2020, selling an estimated $4.67M.
  • James Investment Research's ten largest holdings make up 21% of its $1.11B portfolio in Q4 2020.
  • James Investment Research opened 93 new positions and closed 56 in Q4 2020.
  • James Investment Research's portfolio value rose 2.7% quarter-over-quarter to $1.11B.

Based on James Investment Research's 13F filing for Q4 2020, filed 27 Jan 2021.